Healthcare -
Biotechnology - NASDAQ - US
$ 118.0
0.803 %
$ 11.3 B
Market Cap
76.62
P/E
SRPT - GROSS PROFIT
Gross Profit SRPT - Sarepta Therapeutics, Inc.
1.09 B
LAST VALUE
34.43%
2 YEAR CAGR
32.58%
5 YEAR CAGR
32.25%
10 YEAR CAGR